Tenaya Therapeutics (TNYA) Earnings Date & Reports
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNYA is expected to report earnings to rise 14.33% to -10 cents per share on November 11
Q3'26
Est.
$-0.10
Q1'26
Est.
$-0.09
Q4'25
Est.
$-0.12
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.04
The last earnings report on May 05 showed earnings per share of -9 cents, meeting the estimate of -9 cents. With 725.43K shares outstanding, the current market capitalization sits at 156.36M.